3rd Jun 2013 07:00
Skyepharma to Present at the Jefferies 2013 Global Healthcare Conference
LONDON, UK, 03 June, 2013 - Skyepharma PLC (LSE: SKP), the expert oral and inhalation drug delivery company, today announces that the Company's CEO, Peter Grant, will present at the Jefferies 2013 Global Healthcare Conference in New York on Thursday, June 6, 2013 at 11:00 a.m. Eastern Time (ET), 4:00 p.m. British Summer Time (BST).
A copy of the presentation is available on the Investor Relations section of the Skyepharma website at http://www.skyepharma.com/Investors/Presentations_~_Webcasts/Default.aspx?id=25.
In addition, an audio webcast of the presentation will be available on the Investor Relations section of the Skyepharma website at http://www.skyepharma.com/Investors/Presentations_~_Webcasts/Default.aspx?id=25.
-Ends-
For further information please contact:
Skyepharma PLC | |
Peter Grant, Chief Executive Officer | +44 207 881 0524 |
| |
FTI Consulting | |
Julia Phillips/Susan Stuart/Natalie Garland-Collins | +44 207 831 3113 |
About Skyepharma
Skyepharma combines proven scientific expertise with validated proprietary drug delivery technologies to develop innovative oral and inhalation pharmaceutical products. The Group receives revenues from 14 approved/marketed products in the areas of inhalation, oral, topical and injectable drug delivery as well as generating income from the development of further products and technology licenses. The products developed by the Group are marketed throughout the world by big pharma as well as speciality pharmaceutical companies. For more information, visit www.Skyepharma.com
Related Shares:
SKP.L